{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:07:57Z","timestamp":1780546077610,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jpba.2011.01.019","type":"journal-article","created":{"date-parts":[[2011,1,23]],"date-time":"2011-01-23T09:19:15Z","timestamp":1295774355000},"page":"194-201","source":"Crossref","is-referenced-by-count":39,"title":["LC\u2013MS\/MS method for the simultaneous determination of clarithromycin, rifampicin and their main metabolites in horse plasma, epithelial lining fluid and broncho-alveolar cells"],"prefix":"10.1016","volume":"55","author":[{"given":"Stefan","family":"Oswald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Venner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2011.01.019_bib0005","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1517\/14656560903369363","article-title":"Current treatment of atypical mycobacteriosis","volume":"10","author":"Esteban","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jpba.2011.01.019_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0378-1135(87)90121-0","article-title":"Use of erythromycin\u2013rifampin combination in treatment of Rhodococcus equi pneumonia","volume":"14","author":"Hillidge","year":"1987","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jpba.2011.01.019_bib0015","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2460\/ajvr.67.10.1681","article-title":"Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals","volume":"67","author":"Womble","year":"2006","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.jpba.2011.01.019_bib0020","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/AAC.40.7.1617","article-title":"Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects","volume":"40","author":"Conte","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2011.01.019_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2133\/dmpk.18.104","article-title":"CYP isoforms involved in the metabolism of clarithromycin in vitro: comparison between the identification from disappearance rate and that from formation rate of metabolites","volume":"18","author":"Suzuki","year":"2003","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jpba.2011.01.019_bib0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0090-9556(25)08537-X","article-title":"Metabolism and disposition of clarithromycin in man","volume":"18","author":"Ferrero","year":"1990","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2011.01.019_bib0035","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1124\/dmd.108.022285","article-title":"Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat","volume":"36","author":"Garver","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2011.01.019_bib0040","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","article-title":"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions","volume":"102","author":"Lehmann","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpba.2011.01.019_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","article-title":"The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin","volume":"104","author":"Greiner","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpba.2011.01.019_bib0050","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0006-2952(95)00045-2","article-title":"Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells","volume":"49","author":"Fardel","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2011.01.019_bib0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jchromb.2006.12.027","article-title":"Determination of clarithromycin in human serum by high-performance liquid chromatography after pre-column derivatization with 9-fluorenylmethyl chloroformate: application to a bioequivalence study","volume":"850","author":"Bahrami","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.019_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-4347(96)00064-3","article-title":"Ion-pair high-performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice","volume":"682","author":"Erah","year":"1996","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jpba.2011.01.019_bib0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jchromb.2004.12.003","article-title":"Sensitive determination of clarithromycin in human plasma by high-performance liquid chromatography with spectrophotometric detection","volume":"817","author":"Amini","year":"2005","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.019_bib0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/bmc.111","article-title":"Determination of clarithromycin in human plasma by HPLC with electrochemical detection: validation and application in pharmacokinetic study","volume":"15","author":"Niopas","year":"2001","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2011.01.019_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0021-9673(94)00610-L","article-title":"Liquid chromatographic determination of the macrolide antibiotics roxithromycin and clarithromycin in plasma by automated solid-phase extraction and electrochemical detection","volume":"692","author":"Hedenmo","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2011.01.019_bib0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0378-4347(91)80446-J","article-title":"Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection","volume":"571","author":"Chu","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2011.01.019_bib0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jchromb.2008.06.050","article-title":"Simplified method for determination of clarithromycin in human plasma using protein precipitation in a 96-well format and liquid chromatography\u2013tandem mass spectrometry","volume":"871","author":"Shin","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.019_bib0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1570-0232(01)00566-9","article-title":"Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma","volume":"768","author":"van Rooyen","year":"2002","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.019_bib0095","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/bmc.691","article-title":"Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma","volume":"20","author":"Li","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2011.01.019_bib0100","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.jchromb.2009.04.038","article-title":"Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography\u2013tandem mass spectrometry","volume":"877","author":"de Velde","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.019_bib0105","series-title":"Guidance for Industry \u2013 Bioanalytical Method Validation","author":"Food and Drug Administration (FDA)","year":"2001"},{"key":"10.1016\/j.jpba.2011.01.019_bib0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00210-009-0481-1","article-title":"Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals","volume":"381","author":"Venner","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.jpba.2011.01.019_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0732-8893(92)90055-X","article-title":"Clarithromycin, a unique macrolide A pharmacokinetic, microbiological, and clinical overview","volume":"15","author":"Hardy","year":"1992","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T02:57:39Z","timestamp":1740884259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708511000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0731708511000446"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2011.01.019","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}